SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (14815)12/20/2004 1:23:17 PM
From: Biomaven  Read Replies (3) | Respond to of 52153
 
There are different kinds of Phase IV studies. Some are required by the FDA as a condition of approval. Typically companies shamefully drag their heels on these. Most Phase IV's though are run voluntarily by companies to try to get label expansions. The Vioxx/Celebrex Phase IV's were just such label-expansion trials.

Peter



To: Sam Citron who wrote (14815)12/20/2004 2:14:31 PM
From: Sam Citron  Respond to of 52153
 
Set your TIVOs to record CNBC On Assignment: Death of a Wonderdrug 8 and 11 PM EST tonight, with extensive interview of Forbes Face of the Year, David Graham forbes.com.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News